论文部分内容阅读
目的探讨在新生儿脓毒血症临床治疗中降钙素原的作用及效果。方法 60例新生儿脓毒血症患儿,随机分成观察组与对照组,每组30例。分别于治疗前后进行血液检测,两组采用相同类型方法进行治疗,观察组患儿通过降钙素原进行血液检测,对照组患儿通过血培养进行血液检测。观察两组检测效果。结果经过不同方法检测,治疗前观察组的阳性率为100.0%,对照组的阳性率为80.0%,观察组显著高于对照组,差异具有统计学意义(P<0.05)。治疗后观察组的阳性率为26.7%,对照组的阳性率为6.7%,观察组显著高于对照组,差异具有统计学意义(P<0.05)。结论通过降钙素原检查新生儿脓毒血症患儿的血液情况,可以提高检出率,方便及时对新生儿采取针对性的治疗并检测治疗效果,安全有效,值得临床推广。
Objective To investigate the effect and effect of procalcitonin in the clinical treatment of neonatal sepsis. Methods Sixty neonates with sepsis were randomly divided into observation group (n = 30) and control group (n = 30). Blood tests were performed before and after treatment. Both groups were treated with the same type of treatment. Children in the observation group were tested for blood by procalcitonin, and children in the control group were tested for blood by blood culture. Observed two test results. Results After different methods, the positive rate of the observation group before treatment was 100.0%, the positive rate of the control group was 80.0%, the observation group was significantly higher than the control group, the difference was statistically significant (P <0.05). After treatment, the positive rate of the observation group was 26.7%, the positive rate of the control group was 6.7%, the observation group was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusions The procalcitonin in children with neonatal sepsis examination of blood conditions, can increase the detection rate, to facilitate the timely treatment of neonatal and targeted treatment to detect the treatment, safe and effective, worthy of clinical promotion.